Skip to main content

Rallybio Corp

RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001739410

No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Rallybio Corp changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of RLYB: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders4845−3
Shares31.2M28.3M−2.90M (−9.3%)
Value$10.5M$14.1M+$3.60M (+34.2%)

New holders (6)

Institutions that held Rallybio Corp at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to RLYB in Q3 2025
InstitutionSharesValue% of portfolio
Rangeley Capital, LLC83,007$41.4K0.04%
Prudential Financial Inc38,400$19.2K0.00%
Resources Investment Advisors, LLC.20,000$9.98K0.00%
Citigroup Inc9,895$4.94K0.00%
Rockefeller Capital Management L.P.550$2740.00%
Jones Financial Companies LLLP90$500.00%

Sold out (9)

Institutions that held Rallybio Corp at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of RLYB in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Standard Life Aberdeen plc1,595,262$539.2K
Laurion Capital Management LP735,543$248.6K
Millennium Management LLC179,839$60.8K
Two Sigma Advisers, LP88,900$30.0K
Two Sigma Securities, LLC15,153$5.12K
Jane Street Group, LLC11,742$3.97K
HSBC Holdings PLC10,520$3.50K
Federated Hermes, Inc.2,209$747
Raymond James Financial Inc850$288